Rory Horner's guest appearances

Rory Horner

Global Development Institute podcast

In Pursuit of Development

Warwick Global Development Society - The Podcast

Emma Mawdsley

Jonathan Glennie

Yuen Yuen Ang

Indrajit Roy

Atul Kohli

Nic Cheeseman

Mark Miller

Yukon Huang

Dani Rodrik

Peter Singer

Paul Collier

Stephen Sackur

Bina Agarwal

Branko Milanovic

Chrissie Wellington

OwlTail

In this episode Abby welcomes Dr Rory Horner, senior lecturer in Globalisation and Political Economy at the Global Development Institute attached to the University of Manchester. We chat about the concept of global development, the global value chains of the COVID-19 vaccines and the problems of vaccine distribution

In this episode Abby welcomes Dr Rory Horner, senior lecturer in Globalisation and Political Economy at the Global Development Institute attached to the University of Manchester. We chat about the concept of global development, the global value chains of the COVID-19 vaccines and the problems of vaccine distribution

Dr. Rory Horner: Global value chains of the Covid-19 vaccines and the problem of vaccine distribution

One of the many ways in which India has expanded its influence in global affairs relates to pharmaceutical products. The Indian pharmaceutical sector has enthusiastically highlighted its ability to develop Triple A technology (affordable, available, adaptable). By encouraging research hubs and offering a steady supply of affordable drugs to many countries, including the United States, India has rapidly moved from being a pharmacy for low-income countries to becoming the “pharmacy of the world”. The country’s rapidly growing economy has been a major beneficiary of the astonishing rise of the domestic pharmaceutical industry. In becoming a powerhouse on low-cost generic drugs, India contributes actively to meeting global demands for vaccines, Over the Counter (OTC) medicines and patented drugs.An important factor that has contributed to enhancing the reputation and profitability of Indian pharmaceutical companies abroad has been the government’s tough policy on patents, which has enabled Indian firms to manufacture generic versions of drugs that are much more expensive in countries where they were originally developed. But Indian companies also face numerous challenges in the export market. There is a growing demand to reduce costs even further. And several countries in Latin America, Sub-Saharan Africa and Southeast Asia are trying to protect and promote their domestic industries by introducing new regulations that make Indian imports more expensive. There are also concerns that India has become increasingly dependent on imports from China for so-called “active pharmaceutical ingredients” required for making both advanced and essential medicines.To discuss India’s huge and thriving pharmaceutical industry and the country’s ability to supply affordable vaccines and generic drugs to low-income countries, I am joined by Rory Horner. He is a Senior Lecturer in Globalisation and Political Economy in the Global Development Institute at the University of Manchester. We began by discussing the role and impact of the pharmaceutical industry in global development. Resources:"The world needs pharmaceuticals from China and India to beat coronavirus" (The Conversation, 2020)"India is key for global access to a COVID-19 vaccine – here’s why" (The Conversation, 2020)"The segmented globalisation practices within India’s pharmaceutical industry" (blog, 2017)"Pharmaceuticals and the Global South: a healthy challenge for development theory?" (blog, 2016)"Indian Company Offers to Supply AIDS Drugs at Low Cost in Africa" (New York Times, 2001)Rory Horner on TwitterDan Banik and In Pursuit of Development on Twitter

One of the many ways in which India has expanded its influence in global affairs relates to pharmaceutical products. The Indian pharmaceutical sector has enthusiastically highlighted its ability to develop Triple A technology (affordable, available, adaptable). By encouraging research hubs and offering a steady supply of affordable drugs to many countries, including the United States, India has rapidly moved from being a pharmacy for low-income countries to becoming the “pharmacy of the world”. The country’s rapidly growing economy has been a major beneficiary of the astonishing rise of the domestic pharmaceutical industry. In becoming a powerhouse on low-cost generic drugs, India contributes actively to meeting global demands for vaccines, Over the Counter (OTC) medicines and patented drugs.An important factor that has contributed to enhancing the reputation and profitability of Indian pharmaceutical companies abroad has been the government’s tough policy on patents, which has enabled Indian firms to manufacture generic versions of drugs that are much more expensive in countries where they were originally developed. But Indian companies also face numerous challenges in the export market. There is a growing demand to reduce costs even further. And several countries in Latin America, Sub-Saharan Africa and Southeast Asia are trying to protect and promote their domestic industries by introducing new regulations that make Indian imports more expensive. There are also concerns that India has become increasingly dependent on imports from China for so-called “active pharmaceutical ingredients” required for making both advanced and essential medicines.To discuss India’s huge and thriving pharmaceutical industry and the country’s ability to supply affordable vaccines and generic drugs to low-income countries, I am joined by <a href="https://www.research.manchester.ac.uk/portal/rory.horner.html" rel="nofollow" target="_blank">Rory Horner</a>. He is a Senior Lecturer in Globalisation and Political Economy in the <a href="https://www.research.manchester.ac.uk/portal/en/facultiesandschools/global-development-institute(a40aa6d3-0a16-4415-99ad-67a4942ac9f3).html" rel="nofollow" target="_blank">Global Development Institute</a> at the University of Manchester. We began by discussing the role and impact of the pharmaceutical industry in global development. <ul><li>Resources:<ul><li><a href="https://theconversation.com/the-world-needs-pharmaceuticals-from-china-and-india-to-beat-coronavirus-138388?" rel="nofollow" target="_blank">"The world needs pharmaceuticals from China and India to beat coronavirus"</a> (The Conversation, 2020)</li><li><a href="https://theconversation.com/india-is-key-for-global-access-to-a-covid-19-vaccine-heres-why-144772?utm_medium=amptwitter&amp;utm_source=twitter" rel="nofollow" target="_blank">"India is key for global access to a COVID-19 vaccine – here’s why"</a> (The Conversation, 2020)</li><li><a href="http://blog.gdi.manchester.ac.uk/globalisation-practices-within-indias-pharmaceutical-industry/" rel="nofollow" target="_blank">"The segmented globalisation practices within India’s pharmaceutical industry"</a> (blog, 2017)</li><li><a href="http://blog.gdi.manchester.ac.uk/pharmaceuticals-global-south-healthy-challenge-development-theory/" rel="nofollow" target="_blank">"Pharmaceuticals and the Global South: a healthy challenge for development theory?"</a> (blog, 2016)</li><li><a href="https://www.nytimes.com/2001/02/07/world/indian-company-offers-to-supply-aids-drugs-at-low-cost-in-africa.html?smid=tw-share" rel="nofollow" target="_blank">"Indian Company Offers to Supply AIDS Drugs at Low Cost in Africa"</a> (New York Times, 2001)</li><li><a href="https://twitter.com/rory_horner" rel="nofollow" target="_blank">Rory Horner</a> on Twitter</li><li><a href="https://twitter.com/danbanik" rel="nofollow" target="_blank">Dan Banik</a> and <a href="https://twitter.com/GlobalDevPod" rel="nofollow" target="_blank">In Pursuit of Developmen</a>t on Twitter</li></ul></li></ul>

How India became the "pharmacy of the world" — Rory Horner

Khalid Nadvi

A growing body of research points to the ‘Rise of the South’ and the growth of South–South trade. Rory and Khalid consider the implications of the shifting dynamics of global trade and the greater prominence of Southern actors for the conceptualization of global value chains and global production networks. Find out more about the Global Development Institute:  Website Blog Twitter LinkedIn  Facebook  Newsletter   Intro music Anna Banana by Eaters

A growing body of research points to the ‘Rise of the South’ and the growth of South–South trade. Rory and Khalid consider the implications of the shifting dynamics of global trade and the greater prominence of Southern actors for the conceptualization of global value chains and global production networks. Find out more about the Global Development Institute: <ul> <li><a href="https://gdi.manchester.ac.uk" rel="nofollow" target="_blank">Website</a></li> <li><a href="http://blog.gdi.manchester.ac.uk" rel="nofollow" target="_blank">Blog</a></li> <li><a href="https://twitter.com/GlobalDevInst" rel="nofollow" target="_blank">Twitter</a></li> <li><a href="https://www.linkedin.com/company/globaldevinst/" rel="nofollow" target="_blank">LinkedIn </a></li> <li><a href="https://facebook.com/globaldevinst" rel="nofollow" target="_blank">Facebook</a></li> <li> <a href="https://t.co/nbCntwdJ3G" rel="nofollow" target="_blank">Newsletter</a> </li> </ul> Intro music Anna Banana by Eaters

In conversation: The new face of global trade with Khalid Nadvi & Rory Horner